Test project - Methods for systematic next generation oncology biomarker development
Description
The goal of OncoTrack was to identify and characterize biological markers that will help our understanding of the variable make-up of tumours and how this affects the way patients respond to treatment. Cutting edge laboratory-based genome sequencing techniques coupled to novel computer modelling approaches were used to study both the biological heterogeneity of colon cancers (i.e. patient to patient variability) as well as tumour variation within the patient – for example, by comparing primary tumours with metastases. We believe that the results of this research will allow the identification and qualification of a set of biomarkers that may be used to guide patient therapy, provide immediate feedback upon the effects of treatment and ultimately indicate likely outcome of disease management – i.e. Oncology Tracking!
Accession number
ELU-1-6CEACB-1
Project acronym
Test project - OncoTrack
Project website
Start date
2011-01-01
End date
2016-12-31
Funding
IMI1 - Call 2 (Grant number 115234)
Types
| Accession number | Title | Create date | Study | hosted at UL |
| ELU-2-653668-1 | Test dataset - OncoTrack dataset | 2017-01-05 | OncoTrack study | Yes |
| Title | Primary purpose | Study type | Organism |
| OncoTrack study | Test study - OncoTrack study |
C71104
|
|
